Annual Neurodegenerative Drug Development Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics.

Daniel alkonHanson wadeRobert weinsteinExchange commissionNational institute of healthDrug administrationNeurodegenerative drug development summit onNeurodegenerative drug development summitSynaptogenix incChief scientific officerAnnual neurodegenerative drug development summitTargets restorationSynaptic wiringAdvanced alzheimerNational instituteAnnual neurodegenerative drug development